Finance

Lists
Why is 531146 down 2,83%?
Dive Deeper
531146:BOM
Medicamen Biotech Ltd
288,55 ₹
-2,83%
(-8,40) 1D
16 հոկ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 531146...
Open
287,00 ₹
High
290,00 ₹
Low
282,15 ₹
Mkt. cap
3,87 մլրդ
Avg. vol.
5,49 հզր
Volume
885,00
Dividend
0,35%
Quarterly dividend
0,25 ₹
Ex-dividend date
18 սեպ, 2026 թ.
P/E ratio
33,23
52-wk high
454,00 ₹
52-wk low
210,10 ₹
EPS
8,68 ₹
Shares outstanding
11,70 մլն
No. of employees
405
Open
287,00 ₹
High
290,00 ₹
Low
282,15 ₹
Mkt. cap
3,87 մլրդ
Avg. vol.
5,49 հզր
Volume
885,00
Dividend
0,35%
Quarterly dividend
0,25 ₹
Ex-dividend date
18 սեպ, 2026 թ.
P/E ratio
33,23
52-wk high
454,00 ₹
52-wk low
210,10 ₹
EPS
8,68 ₹
Shares outstanding
11,70 մլն
No. of employees
405
News stories
From web sources and news partners
About Medicamen Biotech Ltd
CEO-
Employees405
Founded1993
Headquarters-
Sector-
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
475,43 մլն
474,43 մլն
592,69 մլն
487,58 մլն
Cost of goods sold
231,53 մլն
237,10 մլն
349,40 մլն
211,20 մլն
Cost of revenue
231,53 մլն
237,10 մլն
349,40 մլն
211,20 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
88,31 մլն
83,73 մլն
146,78 մլն
93,14 մլն
Operating expense
207,18 մլն
206,51 մլն
219,99 մլն
242,38 մլն
Total operating expenses
438,71 մլն
443,61 մլն
569,39 մլն
453,58 մլն
Operating income
36,72 մլն
30,83 մլն
23,30 մլն
34,01 մլն
Other non operating income
-
1,00 հզր
8,26 մլն
-
EBT including unusual items
26,83 մլն
21,11 մլն
50,60 մլն
25,72 մլն
EBT excluding unusual items
26,83 մլն
21,11 մլն
50,56 մլն
25,72 մլն
Income tax expense
5,69 մլն
4,76 մլն
6,13 մլն
7,26 մլն
Effective tax rate
21,19%
22,56%
12,11%
28,22%
Other operating expenses
100,30 մլն
104,51 մլն
55,88 մլն
131,37 մլն
Net income
26,67 մլն
21,87 մլն
37,39 մլն
21,18 մլն
Net profit margin
5,61%
4,61%
6,31%
4,34%
Earnings per share
-
-
-
-
Interest and investment income
-
-
17,39 մլն
-
Interest expense
-9,89 մլն
-9,72 մլն
-3,83 մլն
-8,29 մլն
Net interest expenses
-9,89 մլն
-9,72 մլն
13,56 մլն
-8,29 մլն
Depreciation and amortization charges
18,57 մլն
18,27 մլն
17,33 մլն
17,87 մլն
EBITDA
55,01 մլն
48,10 մլն
40,92 մլն
52,05 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps